Lamstatin - a novel inhibitor of lymphangiogenesis derived from collagen IV

Chemokine-Enhanced Chemotaxis of Lymphangioleiomyomatosis Cells with Mutations in the Tumor Suppressor TSC2 Gene

(2014) G. Pacheco-Rodriguez et al.   JOURNAL OF IMMUNOLOGY

Tumor Endothelial Cells

(2013) A. C. Dudley   Cold Spring Harbor Perspectives in Medicine

Doxycycline inhibits matrix metalloproteinase-2 secretion from TSC2-null mouse embryonic fibroblasts and lymphangioleiomyomatosis cells

(2011) LM Moir et al.   BRITISH JOURNAL OF PHARMACOLOGY

The Angiostatic Protein 16K Human Prolactin Significantly Prevents Tumor-Induced Lymphangiogenesis by Affecting Lymphatic Endothelial Cells

(2011) Virginie Kinet et al.   ENDOCRINOLOGY

Recombinant canstatin inhibits angiopoietin-1-induced angiogenesis and lymphangiogenesis

(2011) Jeon Hwang-Bo et al.   INTERNATIONAL JOURNAL OF CANCER

Molecular mechanisms of lymphangiogenesis in development and cancer

(2011) Imke Albrecht et al.   INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY

Phosphatidylinositol 3-Kinase Isoform-Specific Effects in Airway Mesenchymal Cell Function

(2011) L. M. Moir et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Endostar, a Recombined Humanized Endostatin, Inhibits Lymphangiogenesis and Lymphatic Metastasis of Lewis Lung Carcinoma Xenograft in Mice

(2011) X. Dong et al.   THORACIC AND CARDIOVASCULAR SURGEON

mTOR Activation, Lymphangiogenesis, and Estrogen-Mediated Cell Survival: The “Perfect Storm” of Pro-Metastatic Factors in LAM Pathogenesis

(2010) Jane Yu et al.   Lymphatic Research and Biology

Reduction of Tumstatin in Asthmatic Airways Contributes to Angiogenesis, Inflammation, and Hyperresponsiveness

(2009) Janette K. Burgess et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Type IV collagen alpha chains of the basement membrane in the rat bronchioalveolar transitional segment

(2009) Noriko Hinenoya et al.   ARCHIVES OF HISTOLOGY AND CYTOLOGY

Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth

(2009) Romulo J C Albuquerque et al.   NATURE MEDICINE

The Tyrosine Kinase Inhibitor Cediranib Blocks Ligand-Induced Vascular Endothelial Growth Factor Receptor-3 Activity and Lymphangiogenesis

(2008) C. A. Heckman et al.   CANCER RESEARCH

Lymphangioleiomyomatosis: A review

(2008) Donald W. Hohman et al.   European Journal of Internal Medicine

A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells

(2008) E. D. Karagiannis et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA